Biotalys NV

Market Cap: N/A
Industry: Chemicals & Petrochemicals
ISIN: BE0974386188

EUR

3.04

0.02 (0.66%)

Feb 06

BRU

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tessenderlo Group NV

Biotalys NV

Why is Biotalys NV ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

Poor long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 14.96% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -21.89

Flat results in Dec 24

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -15.56%, its profits have risen by 9.2%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -15.56% returns in the last 1 year, the stock has also underperformed Belgium BEL 20 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Biotalys NV for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Biotalys NV

-15.56%

0.04

56.05%

Belgium BEL 20

27.21%

1.71

15.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

14.96%

EBIT to Interest (avg)

-21.89

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.78

Sales to Capital Employed (avg)

Tax Ratio

9.65%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

8.34

EV to EBIT

-8.36

EV to EBITDA

-9.28

EV to Capital Employed

24.15

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-289.09%

ROE (Latest)

-74.88%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Biotalys NV

Net Profit

Higher at EUR -6.7 MM

than preceding 12 month period ended Dec 2024

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (EUR MM)

EPS

Highest at EUR -0.19

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (EUR)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales